EVANSTON, Ill, Clinical-stage biopharmaceutical company developing transformative therapies for challenging neurologic disorders, has completed a $70 million Series B. Read More
SAN FRANCISCO, CA, Stitch Health announced its Series A funding, led by Bill Gurley of Benchmark, with participation from Y Combinator Continuity. Read More
